JP2025521111A5 - - Google Patents

Info

Publication number
JP2025521111A5
JP2025521111A5 JP2024568194A JP2024568194A JP2025521111A5 JP 2025521111 A5 JP2025521111 A5 JP 2025521111A5 JP 2024568194 A JP2024568194 A JP 2024568194A JP 2024568194 A JP2024568194 A JP 2024568194A JP 2025521111 A5 JP2025521111 A5 JP 2025521111A5
Authority
JP
Japan
Prior art keywords
sequence
raav
seq
arsa
expression cassette
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024568194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025521111A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/067013 external-priority patent/WO2023225481A1/en
Publication of JP2025521111A publication Critical patent/JP2025521111A/ja
Publication of JP2025521111A5 publication Critical patent/JP2025521111A5/ja
Pending legal-status Critical Current

Links

JP2024568194A 2022-05-16 2023-05-15 異染性白質ジストロフィーを治療する方法 Pending JP2025521111A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263342590P 2022-05-16 2022-05-16
US63/342,590 2022-05-16
US202363459564P 2023-04-14 2023-04-14
US63/459,564 2023-04-14
PCT/US2023/067013 WO2023225481A1 (en) 2022-05-16 2023-05-15 Methods of treating metachromatic leukodystrophy

Publications (2)

Publication Number Publication Date
JP2025521111A JP2025521111A (ja) 2025-07-08
JP2025521111A5 true JP2025521111A5 (cg-RX-API-DMAC10.html) 2026-05-22

Family

ID=87155607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024568194A Pending JP2025521111A (ja) 2022-05-16 2023-05-15 異染性白質ジストロフィーを治療する方法

Country Status (12)

Country Link
US (1) US20230398192A1 (cg-RX-API-DMAC10.html)
EP (1) EP4526439A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025521111A (cg-RX-API-DMAC10.html)
KR (1) KR20250011933A (cg-RX-API-DMAC10.html)
CN (1) CN119213120A (cg-RX-API-DMAC10.html)
AU (1) AU2023273809A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253612A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024016901A2 (cg-RX-API-DMAC10.html)
IL (1) IL316984A (cg-RX-API-DMAC10.html)
MX (1) MX2024014114A (cg-RX-API-DMAC10.html)
TW (1) TW202403049A (cg-RX-API-DMAC10.html)
WO (1) WO2023225481A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122206466A (zh) * 2023-11-15 2026-06-12 建新公司 治疗神经变性障碍的方法
WO2026142957A1 (en) * 2024-12-24 2026-07-02 Genzyme Corporation Aav genomes encoding engineered human frataxin transgene

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6596535B1 (en) 1999-08-09 2003-07-22 Targeted Genetics Corporation Metabolically activated recombinant viral vectors and methods for the preparation and use
US7465583B2 (en) 2000-06-01 2008-12-16 The University Of North Carolina At Chapel Hill Duplexed parvovirus vectors
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
US7510872B2 (en) 2003-02-26 2009-03-31 Nationwide Children's Hospital Recombinant adeno-associated virus production
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
US7765583B2 (en) 2005-02-28 2010-07-27 France Telecom System and method for managing virtual user domains
JP5956331B2 (ja) 2009-06-16 2016-07-27 ジェンザイム・コーポレーション 組換えaavベクターの改良された精製方法
JP7715640B2 (ja) * 2019-05-03 2025-07-30 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 異染性白質ジストロフィーの治療に有用な組成物
PE20220233A1 (es) * 2019-06-10 2022-02-07 Homology Medicines Inc Composiciones de virus adenoasociados para la transferencia del gen de arsa y metodos de uso de las mismas
CN115023242B (zh) 2019-11-22 2025-03-14 费城儿童医院 腺相关病毒载体变体

Similar Documents

Publication Publication Date Title
JP2022511453A5 (cg-RX-API-DMAC10.html)
CA2999549C (en) Cns gene delivery using peripheral administration of aav vectors
JP2022531861A5 (cg-RX-API-DMAC10.html)
JP2023503637A5 (cg-RX-API-DMAC10.html)
AU2020204679B2 (en) Gene therapy constructs for treating wilson disease
JP2021529821A5 (cg-RX-API-DMAC10.html)
TW202005978A (zh) 新穎肝靶向腺相關病毒載體
JP2021507687A5 (cg-RX-API-DMAC10.html)
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
US12359219B2 (en) Transgene cassettes designed to express a human MECP2 gene
JP2022523766A5 (cg-RX-API-DMAC10.html)
JP2022541070A5 (cg-RX-API-DMAC10.html)
JP2021508241A5 (cg-RX-API-DMAC10.html)
CA3121211A1 (en) Gene therapies for neurodegenerative disease
JP2023503850A5 (cg-RX-API-DMAC10.html)
JP2022521432A5 (cg-RX-API-DMAC10.html)
JP2024545186A5 (cg-RX-API-DMAC10.html)
JP2023520763A5 (cg-RX-API-DMAC10.html)
JP2018526994A5 (cg-RX-API-DMAC10.html)
JP2024515902A5 (cg-RX-API-DMAC10.html)
JP2025514489A5 (cg-RX-API-DMAC10.html)
JP2023542241A5 (cg-RX-API-DMAC10.html)
JP2020510433A5 (cg-RX-API-DMAC10.html)
JP2022525848A5 (cg-RX-API-DMAC10.html)
RU2019130004A (ru) Генная терапия при глазных заболеваниях